Cerebrospinal Fluid Biomarker Profile in Atypical Alzheimer’s Disease
Atypical cases demonstrated increased tau levels, suggesting earlier and more extensive cortical damage than the amnestic phenotype. These findings underscore the significance of CSF biomarkers in phenotypic differentiation, disease course prediction, and individualized treatment strategies for AD.
Authors
- Javier Sánchez‐Ruiz de Gordoa (ORCID: https://orcid.org/0000-0001-6467-5830)
- Elisa Martínez Campos (ORCID: https://orcid.org/0000-0002-0305-1546)
- Paula Tellechea Aramburo (ORCID: https://orcid.org/0000-0001-8402-5712)
- Rosa Larumbe Ilundain
Institutions
- Complejo Hospitalario de Navarra (ES)
Publication Details
- Journal
- Revista de Neurología
- Published
- 2025-05-22
- DOI
- https://doi.org/10.31083/rn36399
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00